How big pharma could lose the war on disease Biologist Kim Lewis of Northeastern University, who has studied antibiotic development, sees the primary problem as the lack of any method for finding promising compounds. All the amazing progress a half century ago came when U.S. biochemist Selman Waksman developed a technique to systematically screen soil bacteria. This is how he discovered streptomycin, the first treatment […]